DIABETIC NEPHROPATHY

Clinical trials for DIABETIC NEPHROPATHY explained in plain language.

Never miss a new study

Get alerted when new DIABETIC NEPHROPATHY trials appear

Sign up with your email to follow new studies for DIABETIC NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 2 Completed 1

Diabetes drug shows promise in protecting kidneys from damage

Disease control Completed

This study tested whether the diabetes medication canagliflozin could slow the progression of kidney disease in people with diabetes. It involved 308 Japanese patients who already had signs of kidney damage and were taking standard blood pressure medications. Researchers compared…

Matched conditions: DIABETIC NEPHROPATHY

Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

DIABETIC NEPHROPATHY

Get alerted when new DIABETIC NEPHROPATHY trials appear

Diabetes drug shows promise in protecting kidneys from damage